SCHEMBL2490293

SCHEMBL2490293

OCCC(CO)NC(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 2/20 0.38
TRPA1 O75762 3/20 0.37
KIF11 P52732 4/20 0.36
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
DUT P33316 1/20 0.34
KCNH2 Q12809 1/20 0.32
CNR1 P21554 3/20 0.32
CNR2 P34972 3/20 0.32
CYP3A4 P08684 1/20 0.32
MAPK1 P28482 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
TTR P02766 1/20 0.32
KDM4E B2RXH2 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7479981 0.88 KCNN4 (0.43) KCNN4TRPA1KIF11ALDH1A1DUT
SCHEMBL2792112 0.82 KCNN4 (0.37) KCNN4ALDH1A1GAASMN1; SMN2MEN1
SCHEMBL8214268 0.82 CHRM3 (0.40) KCNN4KIF11ALDH1A1GAASMN1; SMN2
SCHEMBL2792114 0.82 KCNN4 (0.37) KCNN4ALDH1A1GAASMN1; SMN2MEN1
SCHEMBL14559281 0.81 KIF11 (0.44) KCNN4KIF11CYP3A4MAPK1KDM4E
SCHEMBL3302423 0.81 KCNN4 (0.47) KCNN4TRPA1KIF11ALDH1A1SMN1; SMN2
SCHEMBL569600 0.81 KIF11 (0.44) KCNN4KIF11CYP3A4MAPK1KDM4E
SCHEMBL3302429 0.81 KCNN4 (0.47) KCNN4TRPA1KIF11ALDH1A1SMN1; SMN2
SCHEMBL569601 0.81 KIF11 (0.44) KCNN4KIF11CYP3A4MAPK1KDM4E
SCHEMBL3856980 0.81 KCNN4 (0.47) KCNN4TRPA1KIF11ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH KCNN4 2642/4885TRPA1 2758/4885KIF11 4556/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 KCNN4 2867/4885TRPA1 2383/4885KIF11 4605/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R KCNN4 2809/4885TRPA1 2390/4885KIF11 4611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.